April 3rd Evening

 

SAGES/KSELS Panel: Gastric Cancer

1:00 PM - 3:00 PM

Session Chair: Ho-Seong Han, MD
Session Co-chair:Jose M. Martinez, MD

Session Description

This session will discuss the current status of laparoscopic gastrectomy and collaboration on the study and clinical practice in this field.

Session Objectives

At the conclusion of this session, participants will be able to:

  • Describe the potential advantages of laparoscopic gastrectomy in terms of patients recovery
  • Discuss the outcomes of a comparative study between laparoscopy and open surgery for the patients with gastric cancer
  • Outline the benefits and challenges of collaborating on an outcomes study between two countries

Session Outline

Time Presentation Title Faculty Name

1pm

Laparoscopic Gastrectomy for Early Gastric Cancer. KLASS* Group, Multi-institutional Study 1 Hyung-Ho Kim, MD PhD

1:20pm

Laparoscopic Gastrectomy for Advanced Gastric Cancer. KLASS* Group, Multi-institutional Study 2

Sang-Uk Han, MD PhD

1:40pm

Endolumenal  and Laparoscopic Management of Gastric Neoplasms Emmanuel  Lo Menzo, MD

2pm

Role of Screening, Surveillance and Adjuvant Therapies of Gastric Neoplasms

Jose Martinez, MD

2:20pm

Screening on Gastric Cancer in Korea

Young-Woo Kim, MD

2:35pm

Endoscopic Approaches to Early Gastric Neoplasm

Sergey Kantsevoy, MD

2:50pm Q&A  

*KLASS = Korean Laparoscopic Gastrointestinal Surgery Study

 


 

Current Management of Rectal Cancer Panel

3:30 PM - 5:00 PM

Session Chair: David Etzioni, MD
Session Co-chair: George J. Chang, MD

Session Description

Evidence-based treatment of rectal cancer involves the appropriate use of surgery, chemotherapy, and radiation treatment. In this session we will review elements of decision-making and their basis in emerging knowledge in the field. This review will be helpful to any surgeon involved in rectal cancer treatment.

Session Objectives

At the conclusion of this session, participants will be able to:

  • Discuss the advantages and disadvantages of extended pelvic lymphadenectomy
  • Describe the advantages and disadvantages of three options for transanal approaches to rectal cancer
  • Discuss national trends in the use of minimally invasive/robotic techniques for rectal cancer surgery

Session Outline

Time Presentation Title Faculty Name

3:30pm

Transanal, TEM, TAMIS: the right approach for the right patient

Mark Whiteford, MD

3:42pm

Minimally Invasive Proctectomy: Where do we stand in 2014?

Alessandro Fichera, MD

3:54pm

Robotic Surgery for Rectal Cancer: Delivering on the promise?

Sonia Ramamoorthy, MD

4:06pm

Role of Pelvic Lymph Node Dissection for Rectal Cancer

Seon-Han Kim, MD

4:18pm

Regionalizing Rectal Cancer Treatment: Do we need “Centers of Excellence“?

John Monson, MD

4:30pm

Panel Discussion

All Faculty